{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:34:56Z","timestamp":1775169296242,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002647","name":"Sungkyunkwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jiph.2024.03.007","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T17:34:24Z","timestamp":1709746464000},"page":"774-779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ineffectiveness of colistin monotherapy in treating carbapenem-resistant Acinetobacter baumannii Pneumonia: A retrospective single-center cohort study"],"prefix":"10.1016","volume":"17","author":[{"given":"Cheon-Hoo","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7763-8940","authenticated-orcid":false,"given":"Si-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoung\u2011Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1262-6815","authenticated-orcid":false,"given":"Kyoung-Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-3328","authenticated-orcid":false,"given":"Yu Mi","family":"Wi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2024.03.007_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","article-title":"Uncovering the mechanisms of Acinetobacter baumannii virulence","volume":"16","author":"Harding","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiph.2024.03.007_bib2","unstructured":"ntimicrobial resistance surveillance in Europe 2023 - 2021 data. Stockholm: European Centre for Disease Prevention and Control and World Health Organization; 2023."},{"key":"10.1016\/j.jiph.2024.03.007_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.799084","article-title":"Major bloodstream infection-causing bacterial pathogens and their antimicrobial resistance in South Korea, 2017\u20132019: Phase I Report from Kor-GLASS","volume":"12","author":"Kim","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiph.2024.03.007_bib4","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/ofid\/ofy293","article-title":"Antimicrobial susceptibility of Acinetobacter calcoaceticus\u2013Acinetobacter baumannii Complex and Stenotrophomonas maltophilia clinical isolates: results from the SENTRY Antimicrobial Surveillance Program (1997\u20132016)","volume":"6","author":"Gales","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiph.2024.03.007_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad428","article-title":"Infectious Diseases Society of America 2023 guidance on the treatment of Antimicrobial resistant gram-negative infections","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2024.03.007_bib6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jiph.2024.03.007_bib7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"28","author":"Levin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2024.03.007_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/374337","article-title":"Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP","volume":"36","author":"Garnacho-Montero","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2024.03.007_bib9","article-title":"Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii \u2013 A systematic review","volume":"8","author":"Ahmed","year":"2023","journal-title":"Health Sci Rev"},{"issue":"12","key":"10.1016\/j.jiph.2024.03.007_bib10","first-page":"1815","article-title":"The association between empirical antibiotic treatment and mortality in severe infections caused by carbapenem-resistant gram-negative bacteria: a prospective study","volume":"67","author":"Zak-Doron","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2024.03.007_bib11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciy988","article-title":"Treatment outcomes of colistin- and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial","volume":"69","author":"Dickstein","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2024.03.007_bib12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jiph.2024.03.007_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijantimicag.2016.05.011","article-title":"Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy","volume":"48","author":"Choi","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jiph.2024.03.007_bib14","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.jiph.2024.03.007_bib15","first-page":"565","article-title":"Dosing guidance for intravenous colistin in critically-ill patients","volume":"64","author":"Nation","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2024.03.007_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jiph.2024.03.007_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","article-title":"The SOFA score\u2014development, utility and challenges of accurate assessment in clinical trials","volume":"23","author":"Lambden","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jiph.2024.03.007_bib18","unstructured":"CLSI-EUCAST Polymyxin Breakpoints Working Group. Recommendations for MIC determination of colistin (polymyxin E). 2016. Available at: \u3008http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/General_documents\/Recommendations_for_MIC_determination_of_colistin_March_2016.pdf\u3009. Accessed 19 September 2023."},{"key":"10.1016\/j.jiph.2024.03.007_bib19","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2023"},{"issue":"12","key":"10.1016\/j.jiph.2024.03.007_bib20","first-page":"3291","article-title":"New pharmacokinetic\/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection","volume":"70","author":"Cheah","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jiph.2024.03.007_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05093-22","article-title":"Prevalence and clinical consequences of colistin heteroresistance and evolution into full resistance in carbapenem-resistant Acinetobacter baumannii","volume":"11","author":"Kon","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"8","key":"10.1016\/j.jiph.2024.03.007_bib22","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/jac\/dkw121","article-title":"High rate of colistin dependence in Acinetobacter baumannii","volume":"71","author":"Hong","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jiph.2024.03.007_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.23838\/pfm.2017.00184","article-title":"Old drug, new findings: colistin resistance and dependence of Acinetobacter baumannii","volume":"1","author":"Ko","year":"2017","journal-title":"Precis Future Med"},{"issue":"4","key":"10.1016\/j.jiph.2024.03.007_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiph.2024.03.007_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jgar.2021.01.018","article-title":"What is the optimal antibiotic treatment strategy for carbapenem-resistant Acinetobacter baumannii (CRAB)? A multicentre study in Korea","volume":"24","author":"Seok","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"34","key":"10.1016\/j.jiph.2024.03.007_bib26","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e263","article-title":"Clinical effectiveness of tetracycline-class agents based regimens in patients with carbapenem-resistant Acinetobacter baumannii Bacteremia: a single-center retrospective cohort study","volume":"38","author":"Kim","year":"2023","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.jiph.2024.03.007_bib27","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/jac\/dkad042","article-title":"Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients","volume":"78","author":"Heil","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jiph.2024.03.007_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/antibiotics9100647","article-title":"A Comparison of colistin versus colistin plus meropenem for the treatment of carbapenem-resistant Acinetobacter baumannii in critically Ill patients: a propensity score-matched analysis","volume":"9","author":"Katip","year":"2020","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.jiph.2024.03.007_bib29","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/pharmaceutics14061266","article-title":"Effectiveness and nephrotoxicity of loading dose colistin\u2013meropenem versus loading dose colistin\u2013imipenem in the treatment of carbapenem-resistant Acinetobacter baumannii infection","volume":"14","author":"Katip","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.jiph.2024.03.007_bib30","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1473-3099(23)00184-6","volume":"23","author":"Kaye","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2024.03.007_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlad085","article-title":"Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study","volume":"5","author":"Rando","year":"2023","journal-title":"JAC-Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.jiph.2024.03.007_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaa101","article-title":"Evaluation of Vitek\u00ae2 performance for colistin susceptibility testing for Gram-negative isolates","volume":"2","author":"Khurana","year":"2020","journal-title":"JAC Antimicrob Resist"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034124000583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034124000583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T22:37:09Z","timestamp":1731537429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034124000583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1876034124000583"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2024.03.007","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ineffectiveness of colistin monotherapy in treating carbapenem-resistant Acinetobacter baumannii Pneumonia: A retrospective single-center cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2024.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}